Stefan Kasper-Virchow
Stefan Kasper-Virchow is an oncologist at the University Hospital Essen in Germany, known for his contributions to cancer research and treatment. He recently gained attention for his involvement in the groundbreaking announcement of a new cancer drug, Daraxonrasib, which has shown significant promise in improving survival rates for patients with pancreatic cancer.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Switzerland | 1 | 9.00 | 0.08% | +0% | 8,654,622 | 6,725 | $700,000 | 544$ |
| Totals | 1 | 8,654,622 | 6,725 | $700,000 | 544$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Stefan Kasper-Virchow is an oncologist from the University Hospital Essen who attended the ASCO Congress and described the atmosphere during the presentation of the new drug.
9